Up 131% in a Day, Is This Hot Stock a Buy?
With shares of Nkarta (NASDAQ: NKTX) up by 131%, April 25 was a great day to be a shareholder of this little-known biotech. Thanks to some great news from a pair of its early-stage clinical projects, this company is officially on the map, though it still has a very long way to go before commercializing any of its medicines in development.
Still, with such a resoundingly optimistic response from the market, buying a few shares of the stock is a tantalizing prospect. Let's take a beat to think about whether it could be a smart move for your portfolio, too.
Image source: Getty Images.
Source Fool.com
